Images of medication Mounjaro Generic Name tirzepatide Strength 2.5 mg/0.5 mL pre-filled single-dose pen Availability Prescription only Drug Class GLP-1 Drugs CSA Schedule Not a controlled drug Labeler / Supplier Eli Lilly and Company National Drug Code (NDC) 00002-1506 More about Mounjaro (tirzepatide) Check interactions Compare alternatives Pricing & coupons Reviews (2,091) Drug images Latest FDA alerts (2) Side effects Dosage information Patient tips During pregnancy Support group FDA approval history Drug class: GLP-1 Drugs Breastfeeding En espaol Patient resources Other brands Professional resources Other brands Related treatment guides Further information Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
10.1111/acps.12711 Acta Psychiatr
Rats treated with a drug called apomorphine exhibit this specific movement pattern observed in animal models of Parkinsons disease
The FDA approved Wegovy 7.2 mg on March 19, 2026, but no randomized head-to-head against tirzepatide at that dose has been published
Key Research Areas Appetite Signaling Pathways Studied for its role in gastric emptying dynamics and hunger-related neural signaling Glucose & Insulin Signaling Investigated for its involvement in insulin sensitivity and glycemic regulation mechanisms Cardiac, Hepatic & Neural Pathways Examined for potential roles in inflammation modulation and tissue integrity signaling Neuroprotective Research Explored in preclinical models for associations with cognitive and neuronal resilience One peptide
Lock in your weight loss journey with exclusive bundle pricing based on your dosage: 2.5mg & 5mg 3 Months $900 upfront ($300/mo) 6 Months $1,700 upfront ($283/mo) 7.5mg & 10mg 3 Months $1,200 upfront ($400/mo) 6 Months $2,300 upfront ($383/mo) 12.5mg & 15mg 3 Months $1,500 upfront ($500/mo) 6 Months $2,900 upfront ($483/mo) Available only to existing Ness patients or those with proof of a previous GLP-1 prescription
